10-Q Filing

BIO GREEN MED SOLUTION, INC. CIK: 1130166 Q1 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-037471`
Period End Date	20120331
Filing Date	20120515
Fiscal Year	2012
Fiscal Period	Q1
XBRL Instance	cycc-20120331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 65 Cash Flow Statement 93 Comprehensive Income 3

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.64M	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$13.89M	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$13.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Inventory	`InventoryFinishedGoodsNetOfReserves`	$109.00K	USD	Point-in-time
Inventory	`InventoryFinishedGoodsNetOfReserves`	$182.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.42M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.20M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$25.17M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	58.99M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.22M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$25.83M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	58.99M	shares	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$166.00K	USD	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$167.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.22M	shares	Point-in-time
Total assets	`Assets`	$26.00M	USD	Point-in-time
Total assets	`Assets`	$25.34M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.12M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.76M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.50M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.66M	USD	Point-in-time
Economic rights	`WarrantsAndRightsOutstanding`	$1.15M	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$29.00K	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$71.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.80M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.50M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011 and March 31, 2012; 1,213,142 shares issued and outstanding at December 31, 2011 and March 31, 2012. Aggregate preference in liquidation of $13,708,505 and $13,890,476 at December 31, 2011 and March 31, 2012, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011 and March 31, 2012; 1,213,142 shares issued and outstanding at December 31, 2011 and March 31, 2012. Aggregate preference in liquidation of $13,708,505 and $13,890,476 at December 31, 2011 and March 31, 2012, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2011 and March 31, 2012; 54,220,458 and 58,993,414 shares issued and outstanding at December 31, 2011 and March 31, 2012, respectively	`CommonStockValue`	$54.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2011 and March 31, 2012; 54,220,458 and 58,993,414 shares issued and outstanding at December 31, 2011 and March 31, 2012, respectively	`CommonStockValue`	$59.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$276.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$278.43M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$65.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.00K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-257.06M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-260.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.54M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$26.00M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$25.34M	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$3.10M	USD	63 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$192.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$3.18M	USD	63 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$161.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$3.65M	USD	63 Qtrs
Total revenues	`SalesRevenueNet`	$9.93M	USD	63 Qtrs
Total revenues	`SalesRevenueNet`	$192.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$161.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$1.85M	USD	63 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$106.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$94.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.35M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.08M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$187.15M	USD	63 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$91.48M	USD	63 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.81M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.00M	USD	1 Quarter
Goodwill and intangible impairment	`GoodwillAndIntangibleAssetImpairment`	$7.93M	USD	63 Qtrs
Restructuring costs	`OtherRestructuringCosts`	$2.63M	USD	63 Qtrs
Total operating expenses	`CostsAndExpenses`	$291.04M	USD	63 Qtrs
Total operating expenses	`CostsAndExpenses`	$3.44M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$4.99M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.80M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-281.11M	USD	63 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.28M	USD	1 Quarter
Costs associated with aborted 2004 IPO	`PaymentsOfFinancingCosts`	$-3.55M	USD	63 Qtrs
Payment under guarantee	`PaymentUnderGuarantee`	$1.65M	USD	63 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$56.00K	USD	63 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$56.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$78.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.41M	USD	63 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$42.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-4.26M	USD	63 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-68.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$114.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$11.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$13.73M	USD	63 Qtrs
Interest expense	`InterestExpense`	$4.68M	USD	63 Qtrs
Other income	`OtherNonoperatingIncome`	$47.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$47.00K	USD	63 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$6.00M	USD	63 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$153.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$21.00K	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.78M	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-275.12M	USD	63 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.12M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-168.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-18.61M	USD	63 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-191.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-256.50M	USD	63 Qtrs
Net loss	`NetIncomeLoss`	$-4.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	1 Quarter
Dividends on preferred ordinary shares	`DividendsOnPreferredOrdinaryShares`	$38.12M	USD	63 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$3.52M	USD	63 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$3.84M	USD	63 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.14M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-301.98M	USD	63 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.77M	USD	1 Quarter
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	46.57M	shares	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.76M	shares	1 Quarter

Cash Flow Statement 93 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-256.50M	USD	63 Qtrs
Net loss	`NetIncomeLoss`	$-4.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	1 Quarter
Accretion of interest on notes payable, net of amortization of debt premium	`AccretionExpense`	$100.00K	USD	63 Qtrs
Amortization of investment premiums, net	`InvestmentIncomeAmortizationOfPremium`	$-2.30M	USD	63 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$56.00K	USD	63 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$56.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$78.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.41M	USD	63 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$42.00K	USD	1 Quarter
Warrant re-pricing	`GainLossOnPriceRiskDerivativesNet`	$-44.00K	USD	63 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$86.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.57M	USD	63 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$886.00K	USD	63 Qtrs
Fixed asset impairment	`ImpairmentOfLongLivedAssetsHeldForUse`	$221.00K	USD	63 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-7.75M	USD	63 Qtrs
Deferred revenue	`RecognitionOfDeferredRevenue`	$98.00K	USD	63 Qtrs
Compensation for warrants issued to non-employees	`StockOptionPlanExpenses`	$1.22M	USD	63 Qtrs
Shares issued for IP rights	`IssuanceOfStocksAndWarrantsForServicesOrClaims`	$446.00K	USD	63 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-53.00K	USD	63 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$47.00K	USD	1 Quarter
Goodwill and intangibles impairment	`GoodwillAndIntangibleAssetImpairment`	$7.93M	USD	63 Qtrs
Stock based compensation	`ShareBasedCompensation`	$102.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$251.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$19.12M	USD	63 Qtrs
Provision for restructuring	`PaymentsForRestructuring`	$-1.78M	USD	63 Qtrs
Amortization of issuance costs of Preferred Ordinary "C" shares	`AmortizationOfFinancingCostsAndDiscounts`	$2.52M	USD	63 Qtrs
Transaction costs on sale of economic rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	63 Qtrs
Transaction costs on sale of economic rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	1 Quarter
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$184.00K	USD	63 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$126.00K	USD	1 Quarter
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-40.00K	USD	1 Quarter
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$397.00K	USD	1 Quarter
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-6.12M	USD	63 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-807.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.89M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.77M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-216.89M	USD	63 Qtrs
Purchase of ALIGN	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.76M	USD	63 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.00K	USD	1 Quarter
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.85M	USD	63 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$187.00K	USD	63 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$24.00K	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$156.66M	USD	63 Qtrs
Redemptions of short-term investments, net of maturities	`ProceedsFromSaleOfShortTermInvestments`	$162.73M	USD	63 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.35M	USD	63 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$15.00K	USD	1 Quarter
Payment of capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$3.72M	USD	63 Qtrs
Proceeds from issuance of ordinary and preferred ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$121.68M	USD	63 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.91M	USD	1 Quarter
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$94.58M	USD	63 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$-80.00K	USD	1 Quarter
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$2.00K	USD	1 Quarter
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$207.00K	USD	63 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$34.00K	USD	1 Quarter
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$1.90M	USD	63 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$182.00K	USD	1 Quarter
Repayment of government loan	`RepaymentsOfNotesPayable`	$455.00K	USD	63 Qtrs
Government loan received	`ProceedsFromNotesPayable`	$414.00K	USD	63 Qtrs
Loan received from Cyclacel Group Plc	`ProceedsFromLoans`	$9.10M	USD	63 Qtrs
Proceeds of committable loan notes issued from shareholders	`ProceedsOfCommittableLoanNotesIssuedFromShareholders`	$8.88M	USD	63 Qtrs
Loans received from shareholders	`LoansAndLeasesReceivableRelatedPartiesCollections`	$-1.65M	USD	63 Qtrs
Cash and cash equivalents assumed on stock purchase	`CashAcquiredFromAcquisition`	$17.91M	USD	63 Qtrs
Costs associated with stock purchase	`PaymentsForRepurchaseOfEquity`	$1.95M	USD	63 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-260.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.94M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$246.40M	USD	63 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.00K	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$476.00K	USD	63 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$7.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-809.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$23.64M	USD	63 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-4.14M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$25.35M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.64M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$25.35M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.64M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Interest	`ProceedsFromInterestReceived`	$11.75M	USD	63 Qtrs
Interest	`ProceedsFromInterestReceived`	$5.00K	USD	1 Quarter
Interest	`ProceedsFromInterestReceived`	$3.00K	USD	1 Quarter
Taxes	`ProceedsFromIncomeTaxRefunds`	$18.21M	USD	63 Qtrs
Interest	`InterestPaidNet`	$-1.91M	USD	63 Qtrs
Acquisitions of equipment purchased through capital leases	`AcquisitionsOfEquipmentPurchasedThroughCapitalLeases`	$3.47M	USD	63 Qtrs
Issuance of common shares in connection with license agreements	`IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements`	$592.00K	USD	63 Qtrs
Issuance of ordinary shares on conversion of bridging loan	`IssuanceOfOrdinarySharesOnConversionOfBridgingLoan`	$1.64M	USD	63 Qtrs
Issuance of preferred ordinary "C" shares on conversion of secured convertible loan notes and accrued interest	`IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest`	$8.89M	USD	63 Qtrs
Issuance of ordinary shares in lieu of cash bonus	`IssuanceOfOrdinarySharesInLieuOfCashBonus`	$164.00K	USD	63 Qtrs
Issuance of other long term payable on ALIGN acquisition	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$1.12M	USD	63 Qtrs

Comprehensive Income 3 line items

Line Item	Tag	Value	Unit	Period
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.95M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$256.44M	USD	63 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.61M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.